EPAS1 and lung adenocarcinoma: In 2021, Yang et al. [88] demonstrated that hsa-miR-182-5p is significantly upregulated in LUAD and regulates lung adenocarcinoma metastasis and epithelial-mesenchymal transition by targeting EPAS1.